Organogenesis Holdings (ORGO) Inventory Average (2019 - 2026)

Organogenesis Holdings' Inventory Average history runs 8 years deep, the most recent figure standing at $29.0 million for Q1 2026.

• In Q1 2026, Inventory Average rose 4.49% year-over-year to $29.0 million; the TTM figure through Mar 2026 stood at $29.0 million (up 4.49% YoY), while the FY2025 annual figure was $27.9 million, up 2.52% from the prior year.
• Inventory Average was $29.0 million for Q1 2026 at Organogenesis Holdings, down from $34.6 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $36.3 million in Q3 2025 to a low of $23.0 million in Q2 2022.
• Historically, Inventory Average has averaged $27.6 million across 5 years, with a median of $27.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Inventory Average dropped 20.5% in 2022, then surged 34.69% in 2025.
• A 5-year view of Inventory Average shows it stood at $24.7 million in 2022, then grew by 13.53% to $28.1 million in 2023, then slipped by 5.17% to $26.6 million in 2024, then grew by 29.96% to $34.6 million in 2025, then fell by 16.12% to $29.0 million in 2026.
• The last three Inventory Average figures came in at $29.0 million (Q1 2026), $34.6 million (Q4 2025), and $36.3 million (Q3 2025), per Business Quant data.